Gene · 48
Papers2,325
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 2,325
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Iron Chelation in Local Infection. | Molecules | 2021 | 33401708 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Hypervirulent and hypermucoviscous extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Klebsiella variicola in Chile. | Virulence | 2021 | 33372844 | PubTator, text mining | PubMed |
| Unconventional endocytosis and trafficking of transferrin receptor induced by iron. | Mol Biol Cell | 2021 | 33236955 | PubTator, text mining | PubMed |
| Fecal host biomarkers predicting severity of Clostridioides difficile infection. | JCI Insight | 2021 | 33232301 | PubTator, text mining | PubMed |
| The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. | Biochimie | 2021 | 33189832 | PubTator, text mining | PubMed |
| MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations. | Nucleic Acids Res | 2021 | 33174596 | PubTator, text mining | PubMed |
Hexafluoropropylene oxide-dimer acid (HFPO-DA or GenX) alters maternal and fetal glucose and lipid metabolism and produces neonatal mortality, low birthweight, and hepatomegaly in the Sprague-Dawley rat. | Environ Int | 2021 | 33126064 | PubTator, text mining | PubMed |
| Predicted iron metabolism genes in hard ticks and their response to iron reduction in Dermacentor andersoni cells. | Ticks Tick Borne Dis | 2021 | 33059171 | PubTator, text mining | PubMed |
| Taurine supplementation associated with exercise increases mitochondrial activity and fatty acid oxidation gene expression in the subcutaneous white adipose tissue of obese women. | Clin Nutr | 2021 | 33051044 | PubTator, text mining | PubMed |
| New insights into the activities and toxicities of the old anticancer drug doxorubicin. | FEBS J | 2021 | 33022843 | PubTator, text mining | PubMed |
| Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model. | Alzheimers Dement | 2021 | 32975365 | PubTator, text mining | PubMed |
| Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. | J Cell Physiol | 2021 | 32959892 | PubTator, text mining | PubMed |
| Iron-sulfur cluster biogenesis, trafficking, and signaling: Roles for CGFS glutaredoxins and BolA proteins. | Biochim Biophys Acta Mol Cell Res | 2021 | 32910989 | PubTator, text mining | PubMed |
| The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia. | Front Immunol | 2020 | 33679722 | PubTator, text mining | PubMed |
| Iron Metabolism in the Tumor Microenvironment: Contributions of Innate Immune Cells. | Front Immunol | 2020 | 33679721 | PubTator, text mining | PubMed |
| Downregulation of CISD2 Has Prognostic Value in Non-Small Cell Lung Cancer and Inhibits the Tumorigenesis by Inducing Mitochondrial Dysfunction. | Front Oncol | 2020 | 33598426 | PubTator, text mining | PubMed |
| Ndfip1 Prevents Rotenone-Induced Neurotoxicity and Upregulation of α-Synuclein in SH-SY5Y Cells. | Front Mol Neurosci | 2020 | 33469419 | PubTator, text mining | PubMed |
| Mitochondrial diseases: expanding the diagnosis in the era of genetic testing. | J Transl Genet Genom | 2020 | 33426505 | PubTator, text mining | PubMed |
| Extracellular Citrate Fuels Cancer Cell Metabolism and Growth. | Front Cell Dev Biol | 2020 | 33425906 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/48/papers?page=40